Guard Medical Inc., a privately-held company today announces enrollment of the first five patients in the post-market study of its NPseal™ at Keck Medical Center of USC. NPseal™ is the next generation, All-in-One Negative Pressure Wound Therapy (NPWT) system for the treatment of closed surgical incisions.
Guard Medical’s simple, innovative and cost-effective NPWT NPseal™ is a wearable dressing with an integrated pump that establishes and maintains negative pressure with just a few pinches.
“The application of negative pressure wound therapy is simple. The dressing maintained negative pressure for the duration of therapy as prescribed by the study protocol,” stated Joongho Shin, MD, colon and rectal surgeon, Keck Medicine of USC, and principal investigator of the study.
“The first cases demonstrate fast application and easy activation of the NPsealTM” stated Machiel van der Leest, CEO of Guard Medical. “This ease of use combined with its cost effectiveness makes prophylactic use of NPWT for closed surgical wounds possible.”
NPWT has been shown to reduce Surgical Site Infections (SSI) in a large number of peer reviewed articles but is in limited use due to its high cost and complexity. While being easy-to-use, NPseal™ delivers the same NPWT as current more expensive and complex NPWT devices.
